PL2415771T3 - Pochodna indolizyny i jej zastosowanie do celów medycznych - Google Patents

Pochodna indolizyny i jej zastosowanie do celów medycznych

Info

Publication number
PL2415771T3
PL2415771T3 PL10758713T PL10758713T PL2415771T3 PL 2415771 T3 PL2415771 T3 PL 2415771T3 PL 10758713 T PL10758713 T PL 10758713T PL 10758713 T PL10758713 T PL 10758713T PL 2415771 T3 PL2415771 T3 PL 2415771T3
Authority
PL
Poland
Prior art keywords
medical purposes
indolizine derivative
indolizine
derivative
medical
Prior art date
Application number
PL10758713T
Other languages
English (en)
Inventor
Kazuo Shimizu
Masato Iizuka
Yasushi Takigawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PL2415771T3 publication Critical patent/PL2415771T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL10758713T 2009-03-31 2010-03-30 Pochodna indolizyny i jej zastosowanie do celów medycznych PL2415771T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009086306 2009-03-31
JP2009279976 2009-12-10
EP10758713.1A EP2415771B1 (en) 2009-03-31 2010-03-30 Indolizine derivative and use thereof for medical purposes
PCT/JP2010/055692 WO2010113942A1 (ja) 2009-03-31 2010-03-30 インドリジン誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
PL2415771T3 true PL2415771T3 (pl) 2014-01-31

Family

ID=42828231

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10758713T PL2415771T3 (pl) 2009-03-31 2010-03-30 Pochodna indolizyny i jej zastosowanie do celów medycznych

Country Status (20)

Country Link
US (1) US8748452B2 (pl)
EP (1) EP2415771B1 (pl)
JP (1) JP5638513B2 (pl)
KR (1) KR101772963B1 (pl)
CN (1) CN102365281B (pl)
AU (1) AU2010231615B2 (pl)
BR (1) BRPI1013432B1 (pl)
CA (1) CA2755132C (pl)
CY (1) CY1114520T1 (pl)
DK (1) DK2415771T3 (pl)
ES (1) ES2429148T3 (pl)
HR (1) HRP20130846T1 (pl)
MX (1) MX2011010395A (pl)
PL (1) PL2415771T3 (pl)
PT (1) PT2415771E (pl)
RU (1) RU2529868C2 (pl)
SI (1) SI2415771T1 (pl)
TW (1) TWI471325B (pl)
WO (1) WO2010113942A1 (pl)
ZA (1) ZA201107085B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130099064A (ko) * 2010-09-29 2013-09-05 깃세이 야쿠힌 고교 가부시키가이샤 (아자)인돌리진 유도체 및 그 의약용도
NO2686520T3 (pl) * 2011-06-06 2018-03-17
KR20140060535A (ko) * 2011-08-24 2014-05-20 깃세이 야쿠힌 고교 가부시키가이샤 축합 헤테로환 유도체 및 그 의약용도
WO2014065275A1 (ja) 2012-10-23 2014-05-01 国立大学法人福井大学 腫瘍融解症候群の治療薬及び予防薬
JP2016520133A (ja) * 2013-05-31 2016-07-11 タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物
HUE066123T2 (hu) 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
EP3392244A1 (en) 2014-02-13 2018-10-24 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015123424A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
LT3105218T (lt) 2014-02-13 2019-12-10 Incyte Corp Ciklopropilaminai kaip lsd1 inhibitoriai
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
CA2974691A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
NZ735973A (en) 2015-04-01 2023-06-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
EA201792205A1 (ru) 2015-04-03 2018-02-28 Инсайт Корпорейшн Гетероциклические соединения как ингибиторы lsd1
DK3334709T3 (da) 2015-08-12 2025-02-03 Incyte Holdings Corp Salte af en lsd1-hæmmer
HUE052608T2 (hu) 2015-09-02 2021-05-28 Sunshine Lake Pharma Co Ltd Karboxi-szubsztituált (hetero) aromás gyûrûs származékok, elõállítási eljárásaik és alkalmazásaik
JP6898330B2 (ja) * 2015-12-28 2021-07-07 シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド インドリジン誘導体、組成物、及び使用方法
CA3021678A1 (en) 2016-04-22 2017-10-26 Incyte Corporation Formulations of an lsd1 inhibitor
US10968215B2 (en) * 2016-09-07 2021-04-06 Shanghai Haihe Pharmaceutical Co., Ltd. Pyrido five-element aromatic ring compound, preparation method therefor and use thereof
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
CN111943957B (zh) * 2019-05-17 2023-01-06 中国医学科学院药物研究所 喹啉甲酰胺类化合物及其制备方法和用途
US12612367B2 (en) 2019-12-10 2026-04-28 Akebia Therapeutics, Inc. Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative
JP2023052711A (ja) * 2020-03-04 2023-04-12 国立研究開発法人理化学研究所 化合物を放出する方法
WO2021216530A1 (en) 2020-04-20 2021-10-28 Akebia Therapeutics, Inc. Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer
AR126164A1 (es) * 2021-06-17 2023-09-27 Lg Chemical Ltd Formulación compuesta para dosificación oral que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxílico
CN115785018A (zh) * 2022-12-26 2023-03-14 湖北广济药业股份有限公司 一种非布司他脱羧杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193926A (en) * 1979-07-06 1984-05-31 Labaz Sanofi Nv 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines
FR2779724B1 (fr) * 1998-06-10 2001-04-20 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2623327A1 (en) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
CA2621038A1 (en) 2005-10-07 2007-04-19 Astellas Pharma Inc. Triarylcarboxylic acid derivative
CN101679251B (zh) 2007-04-11 2013-10-02 橘生药品工业株式会社 (氮杂)吲哚衍生物及其医药用途
MX2009010491A (es) 2007-04-11 2009-11-09 Kissei Pharmaceutical Derivado heterociclico de 5 miembros y su uso para propositos medicos.
WO2008126901A1 (ja) * 2007-04-11 2008-10-23 Kissei Pharmaceutical Co., Ltd. 含窒素複素環化合物およびそれを含有する医薬組成物

Also Published As

Publication number Publication date
US20120015972A1 (en) 2012-01-19
CA2755132A1 (en) 2010-10-07
KR20110132599A (ko) 2011-12-08
JPWO2010113942A1 (ja) 2012-10-11
CN102365281B (zh) 2014-11-12
CA2755132C (en) 2018-02-13
TW201040178A (en) 2010-11-16
ZA201107085B (en) 2012-12-27
WO2010113942A1 (ja) 2010-10-07
MX2011010395A (es) 2011-10-24
DK2415771T3 (da) 2013-10-14
BRPI1013432B1 (pt) 2019-12-17
ES2429148T3 (es) 2013-11-13
HK1165793A1 (en) 2012-10-12
SI2415771T1 (sl) 2013-12-31
CY1114520T1 (el) 2016-10-05
PT2415771E (pt) 2013-10-03
RU2011143741A (ru) 2013-05-10
RU2529868C2 (ru) 2014-10-10
EP2415771A1 (en) 2012-02-08
EP2415771B1 (en) 2013-07-31
AU2010231615A1 (en) 2011-11-03
JP5638513B2 (ja) 2014-12-10
CN102365281A (zh) 2012-02-29
HRP20130846T1 (hr) 2013-11-22
AU2010231615B2 (en) 2014-05-15
BRPI1013432A2 (pt) 2016-04-05
EP2415771A4 (en) 2012-08-29
KR101772963B1 (ko) 2017-08-31
TWI471325B (zh) 2015-02-01
US8748452B2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
ZA201107085B (en) Indolizine derivative and use thereof for medical purposes
IL216955A0 (en) Medical devices and methods
EP2583651A4 (en) ROLLING CHAIR AND BED
GB2509641B (en) Patient interface and aspects thereof
GB2494493B (en) Patient interface and aspects thereof
EP2471437A4 (en) MEDICAL DEVICE
EP2623505A4 (en) (AZA) INDOLIZINE DERIVATIVE AND ITS PHARMACEUTICAL USE
ZA201200797B (en) Bicyclic compound and use thereof for medical purposes
EP2481379A4 (en) MEDICAL CATHETER DEVICE
EP2481355A4 (en) MEDICAL DEVICE
EP2515972A4 (en) MEDICAL DEVICE
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0901795D0 (en) Medical device and method
GB0918392D0 (en) Diagnostic and therapeutic methods
GB0920258D0 (en) New medical agents and use thereof
EP2481378A4 (en) MEDICAL CATHETER DEVICE
GB201209330D0 (en) Movement monitor and use thereof
GB0908425D0 (en) Medical use
GB0903187D0 (en) Medical devices and methods
GB0913300D0 (en) Therapeutic compounds and their use
GB0901610D0 (en) Medical device
GB0920881D0 (en) Medical device
GB0900567D0 (en) Medical device
GB0903193D0 (en) Medical device and method
GB0903190D0 (en) Medical device and method